Loading clinical trials...
Loading clinical trials...
Biomarker-Guided Early Elarithromycin Treatment to Prevent Sepsis Progression in Community-Acquired Pneumonia: The React Randomized Clinical Trial
Conditions
Interventions
Clarithromycin 500mg
Tablets
Locations
24
Greece
5th Pulmonary Department, SOTIRIA Athens General Hospital of Chest Diseases
Athens, Athens, Greece
1st Department of Internal Medicine - General Hospital of Athens "Sismanogleio-Amalia Fleming"
Athens, Greece, Greece
1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki
Athens, Greece, Greece
1st Department of Internal Medicine, EVANGELISMOS Athens General Hospital
Athens, Greece, Greece
1st Department of Internal Medicine, G. GENNIMATAS Athens General Hospital
Athens, Greece, Greece
1st Department of Internal Medicine, General University Hospital of Ioannina
Athens, Greece, Greece
Start Date
February 12, 2024
Primary Completion Date
April 5, 2026
Completion Date
July 30, 2026
Last Updated
December 16, 2025
NCT07278700
NCT07164131
NCT06295120
NCT06114888
NCT02735707
NCT06029933
Lead Sponsor
Hellenic Institute for the Study of Sepsis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions